Optic Atrophy

10 registered clinical trials studyying Optic Atrophy — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Building Research With Artificial Intelligence in Neuro-Ophthalmology NCT06390579	Fondation Ophtalmologique Adolphe de Rothschild	—
Recruiting	Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION NCT05147701	The Foundation for Orthopaedics and Regenerative Medicine	Phase 1
Completed	Natural History Study of SLC25A46 Mutation-related Mitochondriopathy NCT04594590	State University of New York at Buffalo	—
Completed	Natural History Study of FDXR Mutation-related Mitochondriopathy NCT04580979	State University of New York at Buffalo	—
Completed	Systemic Erythropoietin Injection in Patients Having Optic Atrophy NCT04680143	Alexandria University	Phase 1 / Phase 2
Completed	Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph NCT04723160	Visionary Intelligence Ltd.	—
Unknown	Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy NCT02882477	Hadassah Medical Organization	Phase 2 / Phase 3
Recruiting	Stem Cell Ophthalmology Treatment Study II NCT03011541	MD Stem Cells	N/A
Unknown	Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease NCT01834079	Chaitanya Hospital, Pune	Phase 1 / Phase 2
Completed	Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patie NCT01064505	Quark Pharmaceuticals	Phase 1